Angus Liu
2020-01-24
fiercepharma
FiercePharmaAsia—Amgen-Astellas JV; Hengrui's new chairman; coronavirus vaccine development
https://www.fiercepharma.com/pharma-asia/fiercepharmaasia-amgen-astellas-jv-hengrui-s-new-chairman-coronavirus-vaccine
healthcare
On the heels of a China team-up with BeiGene, Amgen is on track to run a Japanese operation independently after buying out an Astellas joint venture. Sun Piaoyang has stepped down as Jiangsu Hengrui Medicines chairman after leading—and making a fortune from—the Chinese pharma major for 30 years. Moderna and Inovio are utilizing their novel platforms to develop vaccines against the new coronavirus thats emerged in China. And more.